Judges Scientific plc (LON:JDG) Insider Bradley Leonard Ormsby Buys 1 Shares of Stock

Judges Scientific plc (LON:JDG) insider Bradley Leonard Ormsby acquired 1 shares of the company’s stock in a transaction on Tuesday, May 7th. The shares were purchased at an average cost of £114.50 ($143.84) per share, with a total value of £114.50 ($143.84).

Bradley Leonard Ormsby also recently made the following trade(s):

• On Monday, April 15th, Bradley Leonard Ormsby sold 20,424 shares of Judges Scientific stock. The shares were sold at an average price of £112 ($140.70), for a total transaction of £2,287,488 ($2,873,728.64).

Judges Scientific Stock Performance

Shares of JDG stock opened at £114 ($143.22) on Thursday. The firm has a market cap of £756.96 million, a PE ratio of 7,972.03, a P/E/G ratio of 0.56 and a beta of 0.88. The company’s fifty day simple moving average is £109.76 and its 200-day simple moving average is GBX 9,845.58. The company has a quick ratio of 0.65, a current ratio of 1.87 and a debt-to-equity ratio of 79.06. Judges Scientific plc has a 12 month low of GBX 7,300 ($91.71) and a 12 month high of £118.98 ($149.47).

Judges Scientific Increases Dividend

The firm also recently declared a dividend, which will be paid on Friday, July 5th. Investors of record on Thursday, June 6th will be paid a GBX 68 ($0.85) dividend. This represents a yield of 0.59%. The ex-dividend date of this dividend is Thursday, June 6th. This is a boost from Judges Scientific’s previous dividend of $27.00. Judges Scientific’s dividend payout ratio is 6,643.36%.

Analyst Ratings Changes

Separately, Shore Capital reissued a “house stock” rating on shares of Judges Scientific in a research note on Thursday, March 21st.

Judges Scientific Company Profile

Judges Scientific plc designs, manufactures, and sells scientific instruments. The company offers engineering teaching and research equipment for universities, colleges, schools, and research centres; and research and development systems for food, beverage, dairy, edible oil, and pharmaceutical industries.